Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
29.46
+0.74 (2.58%)
At close: Jun 12, 2026, 4:00 PM EDT
28.50
-0.96 (-3.26%)
Pre-market: Jun 15, 2026, 7:08 AM EDT
Agios Pharmaceuticals Employees
As of December 31, 2025, Agios Pharmaceuticals had 540 total employees, including 539 full-time and 1 part-time employees. The number of employees increased by 52 or 10.66% compared to the previous year.
Employees
540
Change (1Y)
52
Growth (1Y)
10.66%
Revenue / Employee
$122,311
Profits / Employee
-$782,598
Market Cap
1.75B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 540 | 52 | 10.66% | 539 | 1 |
| Dec 31, 2024 | 488 | 102 | 26.42% | 486 | 2 |
| Dec 31, 2023 | 386 | -7 | -1.78% | 383 | 3 |
| Dec 31, 2022 | 393 | 1 | 0.26% | 389 | 4 |
| Dec 31, 2021 | 392 | -170 | -30.25% | 390 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Intellia Therapeutics | 377 |
| Nurix Therapeutics | 317 |
| Nuvation Bio | 307 |
| Biohaven | 274 |
| Viridian Therapeutics | 252 |
| uniQure | 221 |
| Innoviva | 159 |
AGIO News
- 1 hour ago - Agios Pharmaceuticals price target raised to $54 from $50 at H.C. Wainwright - TheFly
- 14 hours ago - Agios Pharmaceuticals presented results from Phase 3 trial of mitapivat - TheFly
- 1 day ago - Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease - GlobeNewsWire
- 1 day ago - Agios Pharmaceuticals Transcript: EHA 2026 - Transcripts
- 1 day ago - Agios Pharmaceuticals Slides: FY 2026 - Filings
- 4 days ago - Agios Pharmaceuticals price target lowered to $31 from $36 at JPMorgan - TheFly
- 13 days ago - Agios Pharmaceuticals Transcript: Status update - Transcripts
- 13 days ago - Agios Pharmaceuticals Slides: Status update - Filings